Skip to main content
SpringerLink
Log in

Consumption of salt leads to ameliorate symptoms of metabolic disorder and change of gut microbiota

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Purpose

Metabolic diseases caused by high-carbohydrate and/or high-salt diets are becoming major public health concerns. However, the effects of salt on high-carbohydrate diet-induced obesity are unclear. Accordingly, in this study, we investigated the effects of high-salt intake on high-carbohydrate diet-induced obesity.

Methods

We performed a 12-week study on gut microbiota and metabolic changes in high-rice diet (HRD) or HRD supplemented with high-salt (HRS)-fed C57BL/6 J mice by 16S rRNA analysis, glucose and insulin tolerance testing, gut barrier function, western blot and histological analysis. Moreover, the effects of salt on lipid metabolism were confirmed in vitro using 3T3-L1 cells.

Results

High salt intake decreased HRD-induced increases in body and white adipose tissue (WAT) weight. Alternatively, HRS did not reverse the observed increases in glucose intolerance and insulin resistance. Moreover, HRD caused changes in the gut microbiota, thereby impairing gut barrier function and increasing inflammation in the liver. HRS altered HRD-induced microbial composition, however, did not ameliorate gut barrier dysfunction or hepatic inflammation. HRS diets regulated the HRD-induced increase in peroxisome proliferator-activated receptor-γ (PPAR-γ) and lipid metabolism-related protein expression. Moreover, within WAT, HRS was found to reverse the observed decrease in adiponectin and increase in PPAR-γ expression induced by HRD. In vitro, high NaCl concentration also significantly reduced 3T3-L1 cell differentiation and modulated lipid metabolism without causing cytotoxicity.

Conclusion

These results indicate that high salt intake ameliorates metabolic changes associated with a high-rice diet, including changes in fecal microbiota composition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Younossi Z, Tacke F, Arrese M, Sharma BC, Mostafa I, Bugianesi E, Wong VWS, Yilmaz Y, George J, Fan J (2019) Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology 69(6):2672–2682. https://doi.org/10.1002/hep.30251

    Article  Google Scholar 

  2. Park S, Ahn J, Lee B-K (2016) Very-low-fat diets may be associated with increased risk of metabolic syndrome in the adult population. Clin Nutr 35(5):1159–1167. https://doi.org/10.1016/j.clnu.2015.09.010

    Article  CAS  PubMed  Google Scholar 

  3. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, Engell RE, Lim SS, Danaei G, Mozaffarian D (2013) Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 3(12):e003733. https://doi.org/10.1136/bmjopen-2013-003733

    Article  PubMed  PubMed Central  Google Scholar 

  4. Song S, Lee JE, Song WO, Paik H-Y, Song Y (2014) Carbohydrate intake and refined-grain consumption are associated with metabolic syndrome in the Korean adult population. J Acad Nutr Diet 114(1):54–62. https://doi.org/10.1016/j.jand.2013.08.025

    Article  PubMed  Google Scholar 

  5. Villegas R, Liu S, Gao Y-T, Yang G, Li H, Zheng W, Shu XO (2007) Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med 167(21):2310–2316. https://doi.org/10.1001/archinte.167.21.2310

    Article  PubMed  Google Scholar 

  6. Yu D, Shu X-O, Li H, Xiang Y-B, Yang G, Gao Y-T, Zheng W, Zhang X (2013) Dietary carbohydrates, refined grains, glycemic load, and risk of coronary heart disease in Chinese adults. Am J Epidemiol 178(10):1542–1549. https://doi.org/10.1093/aje/kwt178

    Article  PubMed  PubMed Central  Google Scholar 

  7. Basaranoglu M, Basaranoglu G, Bugianesi E (2015) Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatob Surg Nutr 4(2):109–116. https://doi.org/10.3978/j.issn.2304-3881.2014.11.05

    Article  Google Scholar 

  8. Leibowitz A, Volkov A, Voloshin K, Shemesh C, Barshack I, Grossman E (2016) Melatonin prevents kidney injury in a high salt diet-induced hypertension model by decreasing oxidative stress. J Pineal Res 60(1):48–54. https://doi.org/10.1111/jpi.12287

    Article  CAS  PubMed  Google Scholar 

  9. Jiang L, Chen Q, Wu M, Ji T, Liu S, Zhu F, Shi D (2019) Short-term high salt intake impairs hepatic mitochondrial bioenergetics and biosynthesis in SIRT3 knockout mice. Free Radical Res 53(4):387–396. https://doi.org/10.1080/10715762.2019.1580499

    Article  CAS  Google Scholar 

  10. Dornas WC, Cardoso LM, Silva M, Machado NL, Chianca-Jr DA, Alzamora AC, Lima WG, Lagente V, Silva ME (2017) Oxidative stress causes hypertension and activation of nuclear factor-κB after high-fructose and salt treatments. Sci Rep 7:46051. https://doi.org/10.1038/srep46051

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Huang P, Shen Z, Liu J, Huang Y, Chen S, Yu W, Wang S, Ren Y, Li X, Tang C (2016) Hydrogen sulfide inhibits high-salt diet-induced renal oxidative stress and kidney injury in Dahl rats. Oxid Med Cell Longev. https://doi.org/10.1155/2016/2807490

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wang G, Yeung C-k, Wong W-Y, Zhang N, Wei Y-f, Zhang J-l, Yan Y, Wong C-y, Tang J-j, Chuai M (2016) Liver fibrosis can be induced by high salt intake through excess reactive oxygen species (ROS) production. J Agric Food Chem 64(7):1610–1617. https://doi.org/10.1021/acs.jafc.5b05897

    Article  CAS  PubMed  Google Scholar 

  13. Lanaspa MA, Kuwabara M, Andres-Hernando A, Li N, Cicerchi C, Jensen T, Orlicky DJ, Roncal-Jimenez CA, Ishimoto T, Nakagawa T (2018) High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proc Natl Acad Sci 115(12):3138–3143. https://doi.org/10.1073/pnas.1713837115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Takagi Y, Sugimoto T, Kobayashi M, Shirai M, Asai F (2018) High-salt intake ameliorates hyperglycemia and insulin resistance in WBN/Kob-Leprfa/fa rats: a new model of type 2 diabetes mellitus. J Diabetes Res. https://doi.org/10.1155/2018/3671892

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pitynski-Miller D, Ross M, Schmill M, Schambow R, Fuller T, Flynn FW, Skinner DC (2017) A high salt diet inhibits obesity and delays puberty in the female rat. Int J Obes 41(11):1685–1692. https://doi.org/10.1038/ijo.2017.154

    Article  CAS  Google Scholar 

  16. Huehnchen P, Boehmerle W, Endres M (2019) High salt diet ameliorates functional, electrophysiological and histological characteristics of murine spontaneous autoimmune polyneuropathy. Neurobiol Dis 124:240–247. https://doi.org/10.1016/j.nbd.2018.11.017

    Article  CAS  PubMed  Google Scholar 

  17. Wang L, Li P, Tang Z, Yan X, Feng B (2016) Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment. Sci Rep 6:33251. https://doi.org/10.1038/srep33251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8(1):42. https://doi.org/10.1186/s13073-016-0303-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Li H, Limenitakis JP, Fuhrer T, Geuking MB, Lawson MA, Wyss M, Brugiroux S, Keller I, Macpherson JA, Rupp S (2015) The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun 6:8292. https://doi.org/10.1038/ncomms9292

    Article  CAS  PubMed  Google Scholar 

  20. Chen C, You LJ, Huang Q, Fu X, Zhang B, Liu RH, Li C (2018) Modulation of gut microbiota by mulberry fruit polysaccharide treatment of obese diabetic db/db mice. Food Funct 9(7):3732–3742. https://doi.org/10.1039/C7FO01346A

    Article  CAS  PubMed  Google Scholar 

  21. Kim W-G, Kim HI, Kwon EK, Han MJ, Kim D-H (2018) Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-κB activation through restoration of the disturbed gut microbiota. Food Funct 9(8):4255–4265. https://doi.org/10.1039/C8FO00252E

    Article  CAS  PubMed  Google Scholar 

  22. Hamilton MK, Boudry G, Lemay DG, Raybould HE (2015) Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol 308(10):840–851. https://doi.org/10.1152/ajpgi.00029.2015

    Article  CAS  Google Scholar 

  23. Houghton D, Stewart C, Day C, Trenell M (2016) Gut microbiota and lifestyle interventions in NAFLD. Int J Mol Sci 17(4):447. https://doi.org/10.3390/ijms17040447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Clemente-Postigo M, Oliva-Olivera W, Coin-Aragüez L, Ramos-Molina B, Giraldez-Perez RM, Lhamyani S, Alcaide-Torres J, Perez-Martinez P, El Bekay R, Cardona F (2018) Metabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity. Am J Physiol Endocrinol Metab 316(2):E319–E332. https://doi.org/10.1152/ajpendo.00277.2018

    Article  CAS  PubMed  Google Scholar 

  25. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci 104(3):979–984. https://doi.org/10.1073/pnas.0605374104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Cui H, Yang S, Zheng M, Liu R, Zhao G, Wen J (2017) High-salt intake negatively regulates fat deposition in mouse. Sci Rep 7(1):2053. https://doi.org/10.1038/s41598-017-01560-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Magoč T, Salzberg SL (2011) FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27(21):2957–2963. https://doi.org/10.1093/bioinformatics/btr507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, Brown CT, Porras-Alfaro A, Kuske CR, Tiedje JM (2013) Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 42(D1):D633–D642. https://doi.org/10.1093/nar/gkt1244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26(19):2460–2461. https://doi.org/10.1093/bioinformatics/btq461

    Article  CAS  PubMed  Google Scholar 

  30. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–336. https://doi.org/10.1038/nmeth.f.303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Do M, Lee E, Oh M-J, Kim Y, Park H-Y (2018) High-glucose or-fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change. Nutrients 10(6):761. https://doi.org/10.3390/nu10060761

    Article  CAS  PubMed Central  Google Scholar 

  32. Yang T, Zollbrecht C, Winerdal ME, Zhuge Z, Zhang XM, Terrando N, Checa A, Sällström J, Wheelock CE, Winqvist O (2016) Genetic abrogation of adenosine A3 receptor prevents uninephrectomy and high salt–induced hypertension. J Am Heart Assoc 5(7):e003868. https://doi.org/10.1161/JAHA.116.003868

    Article  PubMed  PubMed Central  Google Scholar 

  33. Spadaro PA, Naug HL, Du Toit EF, Donner D, Colson NJ (2015) A refined high carbohydrate diet is associated with changes in the serotonin pathway and visceral obesity. Genet Res. https://doi.org/10.1017/S0016672315000233

    Article  Google Scholar 

  34. Flowers MT, Ntambi JM (2009) Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochim Biophys Acta 1791(2):85–91. https://doi.org/10.1016/j.bbalip.2008.12.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kirpich IA, Marsano LS, McClain CJ (2015) Gut–liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem 48(13–14):923–930. https://doi.org/10.1016/j.clinbiochem.2015.06.023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer R-J (2016) Human intestinal barrier function in health and disease. Clin Transl Gastroenterol 7(10):e196. https://doi.org/10.1038/ctg.2016.54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Zhang C, Zhang M, Pang X, Zhao Y, Wang L, Zhao L (2012) Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J 6(10):1848. https://doi.org/10.1038/ismej.2012.27

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Jang HM, Han SK, Kim JK, Oh SJ, Jang HB, Kim DH (2019) Lactobacillus sakei alleviates high-fat-diet-induced obesity and anxiety in mice by inducing AMPK activation and SIRT1 expression and inhibiting gut microbiota-mediated NF-κB activation. Mol Nutr Food Res 63(6):1800978. https://doi.org/10.1002/mnfr.201800978

    Article  CAS  Google Scholar 

  39. Jeong M-Y, Jang H-M, Kim D-H (2019) High-fat diet causes psychiatric disorders in mice by increasing Proteobacteria population. Neurosci Lett 698:51–57. https://doi.org/10.1016/j.neulet.2019.01.006

    Article  CAS  PubMed  Google Scholar 

  40. Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, Vlieg JE, Strissel K, Zhao L, Obin M (2015) Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9(1):1–15. https://doi.org/10.1038/ismej.2014.99

    Article  CAS  PubMed  Google Scholar 

  41. Jiang W, Wu N, Wang X, Chi Y, Zhang Y, Qiu X, Hu Y, Li J, Liu Y (2015) Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep 5:8096. https://doi.org/10.1038/srep08096

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Araujo JR, Tomas J, Brenner C, Sansonetti PJ (2017) Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity. Biochimie 141:97–106. https://doi.org/10.1016/j.biochi.2017.05.019

    Article  CAS  PubMed  Google Scholar 

  43. Hersoug LG, Møller P, Loft S (2016) Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity. Obes Rev 17(4):297–312. https://doi.org/10.1111/obr.12370

    Article  CAS  PubMed  Google Scholar 

  44. He M, Shi B (2017) Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci 7(1):54. https://doi.org/10.1186/s13578-017-0183-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Rabot S, Membrez M, Bruneau A, Gérard P, Harach T, Moser M, Raymond F, Mansourian R, Chou CJ (2010) Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 24(12):4948–4959. https://doi.org/10.1096/fj.10-164921

    Article  CAS  PubMed  Google Scholar 

  46. Yang Y, Zhong Z, Wang B, Xia X, Yao W, Huang L, Wang Y, Ding W (2019) Early-life high-fat diet-induced obesity programs hippocampal development and cognitive functions via regulation of gut commensal Akkermansia muciniphila. Neuropsychopharmacology 44(12):2054–2064. https://doi.org/10.1038/s41386-019-0437-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Cani PD, Osto M, Geurts L, Everard A (2012) Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3(4):279–288. https://doi.org/10.4161/gmic.19625

    Article  PubMed  PubMed Central  Google Scholar 

  48. Gäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F (2011) DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 55(6):1391–1399. https://doi.org/10.1016/j.jhep.2011.02.035

    Article  CAS  PubMed  Google Scholar 

  49. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML (2003) Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278(36):34268–34276. https://doi.org/10.1074/jbc.M300043200

    Article  CAS  PubMed  Google Scholar 

  50. Zhang Y, Fan S, Hu N, Gu M, Chu C, Li Y, Lu X, Huang C (2012) Rhein reduces fat weight in db/db mouse and prevents diet-induced obesity in C57Bl/6 mouse through the inhibition of PPARγ signaling. PPAR Res. https://doi.org/10.1155/2012/374936

    Article  PubMed  PubMed Central  Google Scholar 

  51. García-Mediavilla MV, Pisonero-Vaquero S, Lima-Cabello E, Benedicto I, Majano PL, Jorquera F, González-Gallego J, Sánchez-Campos S (2012) Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication. Lab Invest 92(8):1191. https://doi.org/10.1038/labinvest.2012.88

    Article  CAS  PubMed  Google Scholar 

  52. Wein S, Behm N, Petersen RK, Kristiansen K, Wolffram S (2010) Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism. Eur J Pharm Sci 41(1):16–22. https://doi.org/10.1016/j.ejps.2010.05.004

    Article  CAS  PubMed  Google Scholar 

  53. Achari A, Jain S (2017) Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci 18(6):1321. https://doi.org/10.3390/ijms18061321

    Article  CAS  PubMed Central  Google Scholar 

  54. Pettinelli P, Videla LA (2011) Up-regulation of PPAR-γ mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. J Clin Endocrinol Metabol 96(5):1424–1430. https://doi.org/10.1210/jc.2010-2129

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by the Main Research Program (E0170602-03) of the Korea Food Research Institute (KFRI) funded by the Ministry of Science and ICT.

Author information

Authors and Affiliations

  1. Research Division of Food Functionality, Korea Food Research Institute, Wanju-gun, Jeollabuk-do, 55365, Republic of Korea

    Moon Ho Do, Hye-Bin Lee, Sang Keun Ha & Ho-Young Park

  2. Technical Assistance Center, Korea Food Research Institute, Wanju-gun, Jeollabuk-do, 55365, Republic of Korea

    Mi-Jin Oh & Hyunjhung Jhun

Authors
  1. Moon Ho Do
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hye-Bin Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mi-Jin Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyunjhung Jhun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sang Keun Ha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ho-Young Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ho-Young Park.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Do, M.H., Lee, HB., Oh, MJ. et al. Consumption of salt leads to ameliorate symptoms of metabolic disorder and change of gut microbiota. Eur J Nutr 59, 3779–3790 (2020). https://doi.org/10.1007/s00394-020-02209-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-020-02209-0

Keywords

Search

Navigation